Daniel J Cobaugh

Summary

Affiliation: American Society of Health-System Pharmacists
Country: USA

Publications

  1. doi request reprint The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems
    Daniel J Cobaugh
    Daniel J Cobaugh, Pharm D, DABAT, FAACT, is Vice President, ASHP Research and Education Foundation, Bethesda, MD Carl Gainor, J D, Ph D, is Clinical Assistant Professor of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA Cynthia L Gaston, Pharm D, BCPS, is Medication Use Policy Analyst, UW Health, Madison, WI Tai C Kwong, Ph D, is Professor of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, and Director, Hematology and Chemistry Labs, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY Barbarajean Magnani, Ph D, M D, is Chair and Pathologist in Chief, Department of Pathology and Laboratory Medicine, Tufts Medical Center, and professor and chair, Department of Anatomic and Clinical Pathology, Tufts University School of Medicine
    Am J Health Syst Pharm 71:1539-54. 2014
  2. doi request reprint Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 70:1404-13. 2013
  3. pmc Rationale and design of the Multicenter Medication Reconciliation Quality Improvement Study (MARQUIS)
    Amanda H Salanitro
    Geriatric Research, Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA
    BMC Health Serv Res 13:230. 2013
  4. ncbi request reprint Adverse drug reactions and therapeutic errors in older adults: a hazard factor analysis of poison center data
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 63:2228-34. 2006
  5. doi request reprint ASHP-SHM Joint Statement on Hospitalist-Pharmacist Collaboration
    Daniel J Cobaugh
    ASHP Research and Education Foundation, 7272 Wisconsin Avenue, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 65:260-3. 2008
  6. doi request reprint Effect of racial differences on ability to afford prescription medications
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 65:2137-43. 2008
  7. doi request reprint Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007
    Cynthia Lacivita
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD, USA
    J Am Pharm Assoc (2003) 49:e110-7. 2009
  8. ncbi request reprint Hydrocarbon toxicity: an analysis of AAPCC TESS data
    Daniel J Cobaugh
    American Society of Health System, Pharmacists Research and Education Foundation, Bethesda, MD, USA
    Przegl Lek 64:194-6. 2007
  9. ncbi request reprint Medication use in the emergency department: why are we placing patients at risk?
    Daniel J Cobaugh
    ASHP Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 62:1832-3. 2005
  10. doi request reprint Risk of major morbidity and death in older adults with suicidal intent: a cross-sectional analysis from the National Poison Data System, 2000-2009
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, Maryland
    J Am Geriatr Soc 63:501-7. 2015

Collaborators

Detail Information

Publications25

  1. doi request reprint The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems
    Daniel J Cobaugh
    Daniel J Cobaugh, Pharm D, DABAT, FAACT, is Vice President, ASHP Research and Education Foundation, Bethesda, MD Carl Gainor, J D, Ph D, is Clinical Assistant Professor of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA Cynthia L Gaston, Pharm D, BCPS, is Medication Use Policy Analyst, UW Health, Madison, WI Tai C Kwong, Ph D, is Professor of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, and Director, Hematology and Chemistry Labs, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY Barbarajean Magnani, Ph D, M D, is Chair and Pathologist in Chief, Department of Pathology and Laboratory Medicine, Tufts Medical Center, and professor and chair, Department of Anatomic and Clinical Pathology, Tufts University School of Medicine
    Am J Health Syst Pharm 71:1539-54. 2014
    ..The current epidemic of prescription opioid abuse and misuse in the United States is discussed, with an emphasis on the pharmacist's role in ensuring safe and effective opioid use...
  2. doi request reprint Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 70:1404-13. 2013
    ..Consensus recommendations to help ensure safe insulin use in hospitalized patients are presented...
  3. pmc Rationale and design of the Multicenter Medication Reconciliation Quality Improvement Study (MARQUIS)
    Amanda H Salanitro
    Geriatric Research, Education and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN, USA
    BMC Health Serv Res 13:230. 2013
    ....
  4. ncbi request reprint Adverse drug reactions and therapeutic errors in older adults: a hazard factor analysis of poison center data
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 63:2228-34. 2006
    ..The severity of hazards posed by medications implicated in poisoning in older adults was characterized...
  5. doi request reprint ASHP-SHM Joint Statement on Hospitalist-Pharmacist Collaboration
    Daniel J Cobaugh
    ASHP Research and Education Foundation, 7272 Wisconsin Avenue, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 65:260-3. 2008
  6. doi request reprint Effect of racial differences on ability to afford prescription medications
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 65:2137-43. 2008
    ..The association of race with not filling prescription medications because of cost for African-American and white patients 65 years or older was examined...
  7. doi request reprint Patient-reported communications with pharmacy staff at community pharmacies: the Alabama NSAID Patient Safety Study, 2005-2007
    Cynthia Lacivita
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, MD, USA
    J Am Pharm Assoc (2003) 49:e110-7. 2009
    ..To examine the prevalence of patient-pharmacy staff communication about medications for pain and arthritis and to assess disparities in communication by demographic, socioeconomic, and health indicators...
  8. ncbi request reprint Hydrocarbon toxicity: an analysis of AAPCC TESS data
    Daniel J Cobaugh
    American Society of Health System, Pharmacists Research and Education Foundation, Bethesda, MD, USA
    Przegl Lek 64:194-6. 2007
    ..To determine which hydrocarbons were associated with the most severe adverse outcomes, human exposure data reported to American poison information centers were analyzed...
  9. ncbi request reprint Medication use in the emergency department: why are we placing patients at risk?
    Daniel J Cobaugh
    ASHP Research and Education Foundation, Bethesda, MD 20814, USA
    Am J Health Syst Pharm 62:1832-3. 2005
  10. doi request reprint Risk of major morbidity and death in older adults with suicidal intent: a cross-sectional analysis from the National Poison Data System, 2000-2009
    Daniel J Cobaugh
    American Society of Health System Pharmacists Research and Education Foundation, Bethesda, Maryland
    J Am Geriatr Soc 63:501-7. 2015
    ..S. poison control centers (PCCs) and report the crude relative risk (RR) of major effects and death from pharmaceuticals and nonpharmaceutical substances after single- and multiple-substance exposures...
  11. doi request reprint Developing and executing an effective research plan
    Robert J Weber
    University of Pittsburgh Medical Center and Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA
    Am J Health Syst Pharm 65:2058-65. 2008
    ..Practical approaches to successful implementation of practice-based research are examined...
  12. ncbi request reprint 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
    Toby L Litovitz
    Am J Emerg Med 20:391-452. 2002
  13. ncbi request reprint Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management
    Lewis S Nelson
    American Association of Poison Control Centers, Washington, District of Columbia 20016 USA
    Clin Toxicol (Phila) 45:315-32. 2007
    ..This should be done in consultation with and authorized by EMS medical direction, by a written treatment protocol or policy, or with direct medical oversight (Grade C)...
  14. ncbi request reprint Pharmacists' role in preventing and treating substance abuse: why are we doing so little?
    Daniel J Cobaugh
    Am J Health Syst Pharm 60:1947. 2003
  15. ncbi request reprint Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons
    Anthony S Manoguerra
    American Association of Poison Control Centers, Washington, District of Columbia 20016, USA
    Clin Toxicol (Phila) 43:1-10. 2005
    ....
  16. ncbi request reprint Academia: A rewarding and critically important career path
    Daniel J Cobaugh
    ASHP Research and Education Foundation
    Am J Health Syst Pharm 62:1204. 2005
  17. ncbi request reprint Camphor Poisoning: an evidence-based practice guideline for out-of-hospital management
    Anthony S Manoguerra
    American Association of Poison Control Centers, Washington, District of Columbia 20016, USA
    Clin Toxicol (Phila) 44:357-70. 2006
    ..It is unlikely that symptoms will progress once the patient is removed from the exposure environment (Grade D)...
  18. ncbi request reprint Long-acting anticoagulant rodenticide poisoning: an evidence-based consensus guideline for out-of-hospital management
    E Martin Caravati
    American Association of Poison Control Centers, Washington, District of Columbia 20016, USA
    Clin Toxicol (Phila) 45:1-22. 2007
    ..11) Patients with dermal exposures should be decontaminated by washing the skin with mild soap and water (Grade D). 12) The administration of vitamin K is not recommended prior to evaluation for coagulopathy (Grade D)...
  19. ncbi request reprint Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management
    Peter A Chyka
    American Association of Poison Control Centers, Washington, District of Columbia 20016, USA
    Clin Toxicol (Phila) 45:95-131. 2007
    ....
  20. doi request reprint Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management
    Anthony S Manoguerra
    American Association of Poison Control Centers, Washington, District of Columbia 20016, USA
    Clin Toxicol (Phila) 46:661-76. 2008
    ..10) A benzodiazepine can be administered by EMS personnel if convulsions are present and if authorized by EMS medical direction, expressed by written treatment protocol or policy, or if there is direct medical oversight (Grade C)...
  21. ncbi request reprint Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management
    Alan D Woolf
    American Association of Poison Control Centers, Washington, District of Columbia, USA
    Clin Toxicol (Phila) 45:203-33. 2007
    ..12) For TCA-associated convulsions, benzodiazepines are recommended (Grade D). 13) Flumazenil is not recommended for patients with TCA poisoning (Grade D)...
  22. doi request reprint Elemental mercury exposure: an evidence-based consensus guideline for out-of-hospital management
    E Martin Caravati
    American Association of Poison Control Centers, Washington, District of Columbia, USA
    Clin Toxicol (Phila) 46:1-21. 2008
    ..The panel recognizes that specific patient care decisions may be at variance with this guideline and are the prerogative of the patient and health professionals providing care. The grade of recommendation is in parentheses...
  23. ncbi request reprint Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management
    Daniel J Cobaugh
    American Association of Poison Control Centers, Washington, District of Columbia, USA
    Clin Toxicol (Phila) 45:918-42. 2007
    ..12) Depending on the specific circumstances, follow-up calls should be made to determine outcome at appropriate intervals based on the clinical judgment of the poison center staff (Grade D)...
  24. ncbi request reprint Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management
    Elizabeth J Scharman
    American Association of Poison Control Centers, Washington, District of Columbia 20016, USA
    Clin Toxicol (Phila) 45:737-52. 2007
    ....
  25. ncbi request reprint Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management
    Peter A Chyka
    American Association of Poison Control Centers, Washington, District of Columbia, USA
    Clin Toxicol (Phila) 45:662-77. 2007
    ..11) Carefully ascertain by history whether other drugs, such as acetaminophen, were involved in the incident and assess the risk for toxicity or for a drug interaction...